Skip to main content
. 2019 Apr 24;38(2):381–388. doi: 10.1007/s00345-019-02770-2

Table 2.

Perioperative parameters of patients with MIBC treated with cystectomy and urinary diversion

Characteristics Total (N = 1340) No preoperative chemotherapy (N = 821) Preoperative chemotherapy (N = 519) P value
Operation time (minutes, mean [SD])a 332 (114) 313 (108) 360 (117) < 0.001
Estimated blood loss (median [IQR])b 650 (300, 1300) 700 (300, 1400) 600 (250, 1100) < 0.001
Transfusion (N [%])c
 No 972 (72.5) 625 (76.1) 347 (66.9) < 0.001
 Yes 368 (27.5) 196 (23.9) 172 (33.1)
 Median (units) (IQR)b 2 (2, 4) 2.5 (2, 5) 2 (2, 4) 0.49
Mode of operation (N [%])c
 Open 1024 (76.4) 653 (79.5) 371 (71.5) < 0.001
 Robotic 315 (23.5) 167 (20.3) 148 (28.5)
 Missing 1 (0.1) 1 (0.1) 0 (0.0)
Diversion (N [%])c
 Ileal conduit 1179 (88.0) 749 (91.2) 430 (82.9) < 0.001
 Neobladder 124 (9.3) 42 (5.1) 82 (15.8)
 Continent cutaneous 10 (0.8) 3 (0.4) 7 (1.4)
 Other 26 (1.9) 26 (3.2) 0 (0.0)
 Missing 1 (0.1) 1 (0.1) 0 (0.0)
Pelvic lymph node dissection (N [%])c
 Aortic bifurcation 264 (19.7) 117 (14.2) 147 (28.3) < 0.001
 Iliac bifurcation 782 (58.4) 479 (58.3) 303 (58.4)
 Obturator fossae 107 (8.0) 73 (8.9) 34 (6.6)
 Enlarged only 36 (2.7) 27 (3.3) 9 (1.7)
 None 149 (11.1) 124 (15.1) 25 (4.8)
 Missing 2 (0.1) 1 (0.1) 1 (0.2)
Length of stay (median [IQR])b 13 (10, 17) 13 (10, 18.5) 13 (10, 16) 0.003

aT test

bWilcoxon rank-sum test

cChi square test or Fisher’s exact test